Taurine fails to protect against 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced striatal dopamine depletion in mice

Amino Acids

Volumn 35, Issue 2, 2008, Pages 457-461

  Navneet, A K ^a   Appukuttan, T A ^a   Pandey, M ^a   Mohanakumar, K P ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

Hydroxyl radical; Mitochondria; MPTP; Parkinson's disease; Striatum; Taurine

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DOPAMINE; TAURINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN PROTECTION; CONTROLLED STUDY; CORPUS STRIATUM; DRUG ACTIVITY; IN VITRO STUDY; MALE; MITOCHONDRION; MOUSE; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; BRAIN; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HYDROXYL RADICAL; INJECTIONS, INTRAPERITONEAL; MALE; MICE; MICE, INBRED BALB C; MITOCHONDRIA; NEURODEGENERATIVE DISEASES; NEURONS; TAURINE; TREATMENT FAILURE;

ANIMALIA; MUS;

EID: 49749117796     PISSN: 09394451     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00726-007-0571-7     Document Type: Article

References (38)

1. J Albrecht A Schousboe 2005 Taurine interaction with neurotransmitter receptors in the CNS: an update Neurochem Res 30 1615 1621
2. T Bouckenooghe C Remacle B Reusens 2006 Is taurine a functional nutrient? Curr Opin Clin Nutr Metab Care 9 728 733
3. RS Burns CC Chiueh SP Markey MH Ebert DM Jacobowitz IJ Kopin 1983 A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine Proc Natl Acad Sci USA 80 4546 4550
4. R Dawson Jr MA Pelleymounter MJ Cullen M Gollub S Liu 1999 An age-related decline in striatal taurine is correlated with a loss of dopaminergic markers Brain Res Bull 48 319 324
5. L Della Corte RR Crichton G Duburs K Nolan KF Tipton G Tirzitis RJ Ward 2002 The use of taurine analogues to investigate taurine functions and their potential therapeutic applications Amino Acids 23 367 379
6. J Dominy Jr JS Thinschmidt J Peris R Dawson Jr RL Papke 2004 Taurine-induced long-lasting potentiation in the rat hippocampus shows a partial dissociation from total hippocampal taurine content and independence from activation of known taurine transporters J Neurochem 89 1195 1205
7. +: implications for neurodegeneration J Neurochem 63 584 591
8. El Idrissi A (2006) Taurine increases mitochondrial buffering of calcium: role in neuroprotection. Amino Acids DOI: 10.1007/s00726-006-0396-9
9. S Engelborghs B Marescau PP De Deyn 2003 Amino acids and biogenic amines in cerebrospinal fluid of patients with Parkinson's disease Neurochem Res 28 1145 1150
10. T Foos JY Wu 2002 The role of Taurine in the central nervous system and the modulation of intracellular calcium homeostasis Neurochem Res 27 21 26
11. B Halliwell H Kaur M Ingelman-Sundberg 1991 Hydroxylation of salicylate as an assay for hydroxyl radicals: a cautionary note Free Radical Biol Med 10 439 441
12. RJ Huxtable 1989 Taurine in the central nervous system and the mammalian actions of taurine Prog Neurobiol 32 471 533
13. JA Javitch RJ D'Amato SM Strittmatter SH Snyder 1985 Parkinsonism- inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity Proc Natl Acad Sci USA 82 2173 2177
14. FJ Jimenez-Jimenez JA Molina C Vargas P Gomez JA Navarro J Benito-Leon M Orti-Pareja T Gasalla E Cisneros J Arenas 1996 Neurotransmitter amino acids in cerebrospinal fluid of patients with Parkinson's disease J Neurol Sci 141 39 44
15. SH Khan A Banigesh A Baziani KG Todd H Miyashita M Eweida A Shuaib 2000 The role of taurine in neuronal protection following transient global forebrain ischemia Neurochem Res 25 217 223
16. VH Knaryan S Samantaray AA Galoyan KP Mohanakumar 2005 A synthetic human proline-rich-polypeptide enhances hydroxyl radical generation and fails to protect dopaminergic neurons against 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced toxicity in mice Neurosci Lett 375 187 191
17. VH Knaryan S Samantaray M Varghese A Srinivasan AA Galoyan KP Mohanakumar 2006 Synthetic bovine proline-rich-polypeptides generate hydroxyl radicals and fail to protect dopaminergic neurons against 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced dopaminergic neurotoxicity in mice Neuropeptides 40 291 298
18. V Leviel A Cheramy A Nieoullon J Glowinski 1979 Symmetric bilateral changes in dopamine release from the caudate nuclei of the cat induced by unilateral nigral application of glycine and GABA-related compounds Brain Res 175 259 270
19. PR Louzada AC Lima DL Mendonca-Silva F Noel FG De Mello ST Ferreira 2004 Taurine prevents the neurotoxicity of beta-amyloid and glutamate receptor agonists: activation of GABA receptors and possible implications for Alzheimer's disease and other neurological disorders FASEB J 18 511 518
20. OH Lowry NJ Rosebrough AL Farr RJ Randall 1951 Protein measurement with the Folin phenol reagent J Biol Chem 193 265 275
21. IN Mankovskaya TV Serebrovskaya RJ Swanson GL Vavilova ON Kharlamova 2000 Mechanisms of taurine antihypoxic and antioxidant action High Alt Med Biol 1 105 110
22. H Mehta B Thomas KP Mohanakumar 2001 Effects of p-chlorophenylalanine on striatal acetylcholinesterase activity and on biogenic amine levels in raphe, tuberculum olfactorium and caudate-putamen during physostigmine-induced tremor in rats Neurosci Lett 299 105 108
23. KP Mohanakumar D Muralikrishnan 2000 Neurochemical mechanisms underlying neuroprotective actions of bromocriptine, salicylate, D- and L-deprenyl in neurodegeneration caused by MPTP MA Collins A Storch Neurotoxic factors in Parkinson's disease and related disorders Kluwer Academic/Plenum Press New York 289 294
24. JA Molina FJ Jiménez-Jiménez P Gómezc C Vargasc JA Navarro M Ortí-Pareja T Gasalla J Benito-León F Bermejo J Arenas 1997 Decreased cerebrospinal fluid levels of neutral and basic amino acids in patients with Parkinson's disease J Neurol Sci 150 123 127
25. MB O'Byrne KF Tipton 2000 Taurine-induced attenuation of MPP+ neurotoxicity in vitro: a possible role for the GABA(A) subclass of GABA receptors J Neurochem 74 2087 2093
26. M Palkovits I Elekes T Lang A Patthy 1986 Taurine levels in discrete brain nuclei of rats J Neurochem 47 1333 1335
27. RR Ramsay TP Singer 1986 Energy-dependent uptake of N-methyl-4- phenylpyridinium, the neurotoxic metabolite of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine, by mitochondria J Biol Chem 261 7585 7587
28. + Neurosci Lett 75 323 328
29. M Ruotsalainen M Heikkila P Lillsunde T Seppala L Ahtee 1996 Taurine infused intrastriatally elevates, but intranigrally decreases striatal extracellular dopamine concentration in anaesthetised rats J Neural Transm 103 935 946
30. K Sairam KS Saravanan R Banerjee KP Mohanakumar 2003 Non-steroidal anti-inflammatory drug sodium salicylate, but not diclofenac or celecoxib, protects against 1-methyl-4-phenyl pyridinium-induced dopaminergic neurotoxicity in rats Brain Res 966 245 252
31. P Saransaari SS Oja 2000 Taurine and neuronal cell damage Amino Acids 19 509 526
32. A Shuaib 2003 The role of taurine in cerebral ischemia: studies in transient forebrain ischemia and embolic focal ischemia in rodents Adv Exp Med Biol 526 421 431
33. S Sola RE Castro PA Laires CJ Steer CM Rodrigues 2003 Tauroursodeoxycholic acid prevents amyloid-beta peptide-induced neuronal death via a phosphatidylinositol 3-kinase-dependent signaling pathway Mol Med 9 226 234
34. M Strolin Benedetti A Russo P Marrai P Dostert 1991 Effects of aging on the content in sulfur-containing amino acids in rat brain J Neural Transm 86 191 202
35. MG Tadros AE Khalifa AB Abdel-Naim HM Arafa 2005 Neuroprotective effect of taurine in 3-nitropropionic acid-induced experimental animal model of Huntington's disease phenotype Pharmacol Biochem Behav 82 574 582
36. B Thomas KP Mohanakumar 2004 Melatonin protects against oxidative stress caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the mouse nigrostiratum J Pineal Res 36 25 32
37. B Thomas D Muralikrishnan KP Mohanakumar 2000 In vivo hydroxyl radical generation in the striatum following systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice Brain Res 852 221 224
38. K Tieu H Ischiropoulos S Przedborski 2003 Nitric oxide and reactive oxygen species in Parkinson's disease IUBMB Life 55 329 335